Concepedia
Statistics
Publications
6
Citations
153
H-Index
Active since
2021
Affiliations
Fudan University(Current)
National Center for Drug Screening
Tel Aviv University
Center for Excellence in Molecular Cell Science
Shanghai Institutes for Biological Sciences
Zhongen Wu is an author at Fudan University.
Publications per year
2021–2024
RORγt agonist enhances anti-PD-1 therapy by promoting monocyte-derived dendritic cells through CXCL10 in cancers
Li Xia, Enming Tian, Mingcheng Yu et al. · Journal of Experimental & Clinical Cancer Research · 2022 · 39 citations · Full text
BCL9 regulates CD226 and CD96 checkpoints in CD8+ T cells to improve PD-1 response in cancer
Mei Feng, Zhongen Wu, Yan Zhou et al. · Signal Transduction and Targeted Therapy · 2021 · 38 citations · Full text
Targeting Wnt Signaling in the Tumor Immune Microenvironment to Enhancing EpCAM CAR T-Cell therapy
Weizhen Li, Yang Zhou, Zhongen Wu et al. · Frontiers in Pharmacology · 2021 · 28 citations · Full text
Targeting BCL9/BCL9L enhances antigen presentation by promoting conventional type 1 dendritic cell (cDC1) activation and tumor infiltration
Fenglian He, Zhongen Wu, Chenglong Liu et al. · Signal Transduction and Targeted Therapy · 2024 · 21 citations · Full text
Inhibition of BCL9 Modulates the Cellular Landscape of Tumor-Associated Macrophages in the Tumor Immune Microenvironment of Colorectal Cancer
Zhuang Wei, Mengxuan Yang, Mei Feng et al. · Frontiers in Pharmacology · 2021 · 15 citations · Full text
1–5 of 6